The Somatic Connection  |   January 2016
Myofascial Trigger Point Release Massage Therapy Relieves Tension-Type Headaches
Author Affiliations
  • Abdulrahman Rahim, OMS II
    Western University of Health Sciences College of Osteopathic Medicine of the Pacific, Lebanon, Oregon
  • Michael A. Seffinger, DO
    Western University of Health Sciences College of Osteopathic Medicine of the Pacific, Pomona, California
Article Information
The Somatic Connection   |   January 2016
Myofascial Trigger Point Release Massage Therapy Relieves Tension-Type Headaches
The Journal of the American Osteopathic Association, January 2016, Vol. 116, 55-56. doi:10.7556/jaoa.2016.009
The Journal of the American Osteopathic Association, January 2016, Vol. 116, 55-56. doi:10.7556/jaoa.2016.009
Web of Science® Times Cited: 18
Moraska AF, Stenerson L, Butryn N, Krutsch JP, Schmiege SJ, Mann JD. Myofascial trigger point-focused head and neck massage for recurrent tension-type headache: a randomized, placebo-controlled clinical trial. Clin J Pain. 2015;31(2):159-168. doi:10.1097/AJP.0000000000000091. 
As a result of the high prevalence of tension-type headache (TTH) and adverse effects from analgesic pharmaceutical treatment, there is interest in nonpharmacologic treatment options. Researchers in the United States have examined one of these options, focusing on the efficacy of using trigger point release (TPR) massage therapy on myofascial trigger points (MTrPs) to decrease headache pain. 
This randomized placebo-controlled trial included 56 participants with TTH. Outcomes were measured during the 4 weeks before treatment, 6 weeks of treatment, and 4 weeks after treatment cessation. Participants were divided into a massage (n=17), placebo (n=19), or wait-list (n=20) group. Those in the massage group received a standardized treatment, which included TPRs aimed at the MTrPs in the sternocleidomastoids, suboccipital, and upper trapezius muscles. The massages were administered by massage therapists who had previous experience in MTrPs identification and had completed training sessions to ensure treatment standardization. Detuned ultrasonography was used in the placebo group. The wait-list group received no treatments but was involved in all outcomes measured. Six participants withdrew from the trial. 
First Page Preview
First page PDF preview
First page PDF preview ×
View Large

Subscribe to view more

For full access to this article, log in to an existing user account, purchase an annual subscription, or purchase a short-term subscription.

Order a subscription

Subscribe

Pay Per View

Entire Journal
30-Day Access

$30.00

Buy Now

This Issue
7-Day Access

$15.00

Buy Now

This article
24-Hour Access

$5.00

Buy Now

Sign In Or Create an account

Please sign in using your Osteopathic.org login.
If you do not have an AOA login, you may create a new account.

Or Subscribe